We have designed and built a state-of-the-art, purpose-built cell manufacturing and cleanroom facility from the ground up — optimized specifically for clinical islet cell isolation and processing.
Every aspect of the facility — from layout and airflow to equipment selection and workflow — was engineered to support highly efficient, reproducible standard operating procedures (SOPs) that maximize islet yield, viability, and safety.
Our customized infrastructure and procedural workflow enables rapid processing of both normal and diseased pancreatic tissue while maintaining strict regulatory compliance and minimizing cold ischemia time.
Our platform is built to meet and exceed the regulatory requirements for clinical cell therapy processing in the United States.
This platform represents a significant advancement in autologous islet cell therapy, allowing us to deliver consistent, high-quality islet preparations that give patients with chronic pancreatitis and other pancreatic conditions the best possible chance for restored endocrine function and improved quality of life. By combining purpose-built infrastructure with deep procedural expertise, IsleNova delivers islet preparations that maximize transplant viability and long-term outcomes.
Interested in partnering with IsleNova for your surgical program? Register your interest or contact us to discuss your program's needs.